Anticancer activity of a thymidine quinoxaline conjugate is modulated by cytosolic thymidine pathways

BACKGROUND: High levels of thymidine kinase 1 (TK1) and thymidine phosphorylase (TYMP) are key molecular targets by thymidine therapeutics in cancer treatment. The dual roles of TYMP as a tumor growth factor and a key activation enzyme of anticancer metabolites resulted in a mixed outcome in cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Qiong, Liu, Haijuan, Zhou, Honghao, Zhang, Dejun, Zhang, Zhiwei, Zhou, Qibing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374574/
https://www.ncbi.nlm.nih.gov/pubmed/25881156
http://dx.doi.org/10.1186/s12885-015-1149-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374574/
https://www.ncbi.nlm.nih.gov/pubmed/25881156
http://dx.doi.org/10.1186/s12885-015-1149-5

Ejemplares similares